---
figid: PMC6213971__ijms-19-03282-g001
figlink: /pmc/articles/PMC6213971/figure/ijms-19-03282-f001/
number: F1
caption: Regulation of PTPIP51 interactions in normal cells (represented by the HaCat
  cell line). Activation of the EGFR via the binding of EGF induces an activation
  of Raf-1 via several signaling molecules. Raf-1 depicts the MAPKKK of the ERK signaling.
  Its activation triggers a signaling cascade via MEK1/2 and ERK1/2, which ultimately
  initiates transcription. The EGFR also phosphorylates the Tyr176 residue of PTPIP51
  and thereby inhibits its interaction with Raf-1. This mechanism prevents an overshooting
  activation of the MAPK pathway. The right side of the figure represents the interactions
  when EGFR is inhibited. The inhibition of EGFR leads to an omission of Tyr176 phosphorylation
  of PTPIP51 via the EGFR. The dephosphorylation of PTPIP51 at Tyr176 induces the
  formation of the Raf-1/14-3-3β/PTPIP51 complex and thus a stimulation of the MAPK
  pathway. This mechanism partially compensates for the EGFR inhibition (black arrows
  indicate a phosphorylation/activation; dotted black arrows indicate a reduced phosphorylation/activation)
  (A); regulation of PTPIP51 interactions in insulin resistance. Activation of the
  insulin receptor induces the activation of the PI3K-Akt-mTOR signaling and the MAPK
  pathway, especially the ERK signaling. Here, PTPIP51 stimulates the signaling on
  Raf-1 level and potentially modulates the insulin sensitivity on transcriptional
  level. Protein kinase A (PKA) phosphorylates the Ser46 residue of PTPIP51 and thereby
  stimulates the binding of PTPIP51 and Raf-1 via 14-3-3β (black arrows indicate a
  phosphorylation/activation) (B).
pmcid: PMC6213971
papertitle: 'The Importance of the Right Framework: Mitogen-Activated Protein Kinase
  Pathway and the Scaffolding Protein PTPIP51.'
reftext: Eric Dietel, et al. Int J Mol Sci. 2018 Oct;19(10):3282.
pmc_ranked_result_index: '31405'
pathway_score: 0.9184264
filename: ijms-19-03282-g001.jpg
figtitle: Regulation of PTPIP51 interactions in normal cells (represented by the HaCat
  cell line)
year: '2018'
organisms:
- Homo sapiens
ndex: dbfd4157-dea1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6213971__ijms-19-03282-g001.html
  '@type': Dataset
  description: Regulation of PTPIP51 interactions in normal cells (represented by
    the HaCat cell line). Activation of the EGFR via the binding of EGF induces an
    activation of Raf-1 via several signaling molecules. Raf-1 depicts the MAPKKK
    of the ERK signaling. Its activation triggers a signaling cascade via MEK1/2 and
    ERK1/2, which ultimately initiates transcription. The EGFR also phosphorylates
    the Tyr176 residue of PTPIP51 and thereby inhibits its interaction with Raf-1.
    This mechanism prevents an overshooting activation of the MAPK pathway. The right
    side of the figure represents the interactions when EGFR is inhibited. The inhibition
    of EGFR leads to an omission of Tyr176 phosphorylation of PTPIP51 via the EGFR.
    The dephosphorylation of PTPIP51 at Tyr176 induces the formation of the Raf-1/14-3-3β/PTPIP51
    complex and thus a stimulation of the MAPK pathway. This mechanism partially compensates
    for the EGFR inhibition (black arrows indicate a phosphorylation/activation; dotted
    black arrows indicate a reduced phosphorylation/activation) (A); regulation of
    PTPIP51 interactions in insulin resistance. Activation of the insulin receptor
    induces the activation of the PI3K-Akt-mTOR signaling and the MAPK pathway, especially
    the ERK signaling. Here, PTPIP51 stimulates the signaling on Raf-1 level and potentially
    modulates the insulin sensitivity on transcriptional level. Protein kinase A (PKA)
    phosphorylates the Ser46 residue of PTPIP51 and thereby stimulates the binding
    of PTPIP51 and Raf-1 via 14-3-3β (black arrows indicate a phosphorylation/activation)
    (B).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CD
  - YWHAQ
  - PIK3CG
  - PIK3R4
  - EGF
  - EGFR
  - AKT3
  - PIK3R3
  - PIK3CA
  - PIK3CB
  - AKT1
  - PIK3R5
  - MAP2K2
  - PIK3R6
  - RAF1
  - MAPK14
  - PRKAR2A
  - RMDN3
  - AKT2
  - PRKAR1B
  - MAPK1
  - MAP2K1
  - PRKACA
  - PRKACB
  - PRKACG
  - MAPK3
  - MAPK8
  - MAPK13
  - MAPK12
  - PRKAR2B
  - MAPK10
  - MAPK11
  - PRKAR1A
  - MAPK9
  - Cancer
genes:
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: 14-3-3
  symbol: 14-3-3
  source: hgnc_alias_symbol
  hgnc_symbol: YWHAQ
  entrez: '10971'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Raf-1
  symbol: Raf-1
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PTPIP51
  symbol: PTPIP51
  source: hgnc_alias_symbol
  hgnc_symbol: RMDN3
  entrez: '55177'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6213971__F1
redirect_from: /figures/PMC6213971__F1
figtype: Figure
---
